CONTEXT THERAPEUTICS INC. Operating Lease Right-of-Use Assets
CONTEXT THERAPEUTICS INC. (CNTX) had Operating Lease Right-of-Use Assets of $241.22 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Operating Lease, Right-of-Use Asset $241.22K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $280.05K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $110.41K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $138.62K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $241.22K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $280.05K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $110.41K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $138.62K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $166.08K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $192.80K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $218.82K 10-K · filed 2026-03-23 |
| 2024-09-30 | $244.13K 10-Q · filed 2024-11-06 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $7.52K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $29.89K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $51.97K 10-K · filed 2024-03-21 |
| 2022-09-30 | $73.75K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $95.25K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $116.47K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |